AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca cost of sales ($M) ($M)
Consolidated Income Statement (Postgres DB + Form 6-K Q1–Q4)
Latest, Q2 2026
2,523
Period ended Jun 30, 2026
Change on a year earlier
+2.0%
2,473 in Q2 2025
History
27 quarters
Since Q2 2017
Sources
26
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AstraZeneca Cost of sales ($M) ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_cor
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.